Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
Neurocrine Biosciences, Inc. (NBIX) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $16.61B, a trailing price-to-earnings ratio of 18.5 and a free-cash-flow yield of 4.5%. Over the most recent reported fiscal year, revenue grew 21.4% and free cash flow per share grew 35.9%.